AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Could Artemis Uncover Hidden Gold Reserves in the Pilbara?
February 10, 2025 07:30 PM AEDT| By Team Kalkine MediaCould Artemis Uncover Hidden Gold Reserves in the Pilbara?
Cardiogeni (AQSE: CGNI) Signs Memorandum of Understanding with UAE Private Office of Sheikh Al Qassimi
February 10, 2025 06:18 PM AEDT| By Team Kalkine MediaHighlights,Cardiogeni secures £20 million funding for heart failure clinical trials in UAE.,Joint venture with UAE Private Office to develop medicines for GCC region.,Initial investment of £5 million planned for H1 2025 to accelerate trials.,Cardioge...
Could Faron's New Fundraising Boost Breakthroughs in Cancer Therapy?
February 10, 2025 04:30 PM AEDT| By Team Kalkine MediaCould Faron's New Fundraising Boost Breakthroughs in Cancer Therapy?
Biotechnology Sector: Oncimmune's Strategic Growth and Industry Leadership
February 09, 2025 03:30 AM AEDT| By Team Kalkine MediaIn Case You Missed It: Insights from Oncimmune's CEO on Projected 2025 Growth and Upcoming Deals
Could This Breakthrough in DNA Analysis Transform Liquid Biopsies?
February 08, 2025 11:30 PM AEDT| By Team Kalkine MediaCould This Breakthrough in DNA Analysis Transform Liquid Biopsies?
Faron Pharmaceuticals (AIM:FARN) Strategic Funding and Clinical Progress in Cancer Immunotherapy
February 06, 2025 11:29 PM AEDT| By Team Kalkine MediaFaron Pharmaceuticals (AIM:FARN) Strategic Funding and Clinical Progress in Cancer Immunotherapy
AstraZeneca (LSE:AZN) Navigating Regulatory Challenges and Strategic Growth in Pharma
February 06, 2025 11:28 PM AEDT| By Team Kalkine MediaAstraZeneca (LSE:AZN) Navigating Regulatory Challenges and Strategic Growth in Pharma
AstraZeneca Reports 21% Revenue Growth in FY24, Driven by 19% Rise in Product Sales
February 06, 2025 06:51 PM AEDT| By Team Kalkine MediaHighlights,Revenue Surge:,AstraZeneca’s total revenue rose by,21%,to,$54.1 billion,, led by,19% growth in product sales,and continued momentum in partnered medicines.,Earnings & Dividend Boost:,Core earnings per share (EPS) climbed,19%,to,$8.21,, wit...
STERIS (NYSE:STE) Sees 42% Growth Over Five Years Despite Recent Decline
February 05, 2025 08:16 PM AEDT| By Team Kalkine MediaHighlights,Share Price Rises Over Five Years,STERIS (STE) recorded a 42% increase over the past five years, reflecting steady growth.,Recent Performance Declines,The stock declined by 2.9% in the last year despite long-term gains.,Earnings Growth Out...
Oxford BioDynamics (AIM: OBD) Announces Breakthrough Colorectal Cancer Detection Technology with High Accuracy in Multi-Centre Study
February 05, 2025 06:31 PM AEDT| By Team Kalkine MediaHighlights,EpiSwitch® 3D genomics platform demonstrates 81% accuracy for early-stage CRC detection.,Non-cancerous polyps identified with 82% accuracy using blood-based test.,Collaboration with leading institutions shows promising diagnostic potential...
_02_04_2025_16_36_34_782763.jpg)
Bioventix (LON:BVXP) Stock Drops Below Two-Hundred-Day Moving Average
February 04, 2025 08:34 PM AEDT| By Team Kalkine MediaBioventix (BVXP) saw its stock price dip below the two-hundred-day moving average.,The stock traded as low as GBX 3,051, signaling a shift in its price trend.,The company’s shares experienced a low trading volume of 3,715 shares.,Bioventix PLC (LON:B...
RUA Life Sciences Delivers Positive Performance from ABISS French Subsidiary Following Acquisition
February 03, 2025 06:22 PM AEDT| By Team Kalkine MediaHighlights:,Revenue Growth:,ABISS achieved €2.3 million in revenue for the year to December 2024, marking a 7% increase over 2023.,Profit Turnaround:,The subsidiary recorded a profit before tax of €46k, a significant recovery from the previous year’s...
Alliance Pharma Reports Stable Revenues in 2024 Trading Update
January 31, 2025 06:51 PM AEDT| By Team Kalkine MediaHighlights,Total revenues for 2024 reached £180.3 million, marking a 1% YoY decline but a 1% increase at constant exchange rates (CER).,Consumer healthcare revenue dropped by 2% CER, while prescription medicine revenue saw an 8% CER rise.,The company...
CSL Limited (ASX:CSL) Analyzing 5-Year Earnings Growth Amidst Share Price Decline
January 31, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,CSL’s share price dropped 13% over five years despite steady earnings growth.,The company's earnings per share (EPS) increased by 5.2% annually during this period.,Revenue growth outpaced market expectations, rising 11% per year.,CSL Limit...
CVS Group Reports 6.6% Increase in Sales for H1 2025 Amid Market Challenges
January 30, 2025 06:40 PM AEDT| By Team Kalkine MediaHighlights,Sales Growth:,Group sales up 6.6%, totaling £341.8m for H1 2025.,Adjusted EBITDA:,Increased by 4.5% to £67.4m, with an EBITDA margin of 19.7%.,Expansion into Australia:,Investment focus shifting to Australia, with no new UK acquisitions du...
hVIVO Acquires Two Clinical Research Units in €10M Deal to Expand European Footprint
January 29, 2025 06:46 PM AEDT| By Team Kalkine MediaHighlights,hVIVO acquires two German clinical research units,from CRS for,€10 million,in cash.,Expands services to include Phase I and II trials,across multiple therapeutic areas.,Strengthens European presence,with,120-bed capacity,across two sites i...
ImmuPharma (LON:IMM) Trading Up 9.3%: Positive Movement in Specialty Biopharma
January 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma's (IMM) share price surged by 9.3% on Saturday.,The company saw significant trading volume with a 60% increase from average daily shares.,ImmuPharma is known for developing peptide-based therapeutics targeting autoimmune disease...
Hikma Pharmaceuticals (LON:HIK) Hits New 52-Week High Amid Positive Market Sentiment
January 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Hikma Pharmaceuticals reaches a new 52-week high, signaling strong market performance.,Stock shows impressive growth with a significant increase in trading volume.,The company's solid fundamentals indicate a robust position in the pharmace...
hVIVO Secures £2.7m Laboratory Services Contract, Marking Largest Standalone Deal to Date
January 21, 2025 07:18 PM AEDT| By Team Kalkine MediaHighlight,Major Contract Win:,hLAB signs a £2.7m contract for a Phase 2 influenza drug trial, bringing the project's total value to £3.2m.,International Scope:,hLAB to support a multi-site Phase 2 study involving 5,000 subjects.,Expanded Laboratory C...
Creo Medical Group PLC (LON:CREO) Insider Purchase Reflects Confidence Amid Market Activity
January 21, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Christopher Paul Hancock acquired 4,712 shares of Creo Medical Group (CREO).,The stock opened lower on Tuesday, reflecting a slight market dip.,Creo Medical Group focuses on advancing electrosurgical medical devices in endoscopy.,Creo Medi...
AI on the Rise: A Look at Top AI Companies and Their Stocks